Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.34 USD | +8.07% |
|
+37.10% | +238.19% |
07-15 | Second malaria vaccine launched in Ivory Coast in new milestone | RE |
07-02 | Novavax Seeks Health Canada Approval for Updated Covid-19 Vaccine | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+238.19% | 2.12B | |
+27.06% | 46.56B | |
+45.38% | 41.67B | |
+0.03% | 41.16B | |
+32.46% | 32.4B | |
+20.83% | 28.18B | |
-6.35% | 28.1B | |
+48.96% | 14.52B | |
+47.91% | 13.74B | |
+3.16% | 12.17B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Transcript : Novavax, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 05